Sympathetic Augmentation in Hypertension
Top Cited Papers
- 1 February 2004
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 43 (2) , 169-175
- https://doi.org/10.1161/01.hyp.0000103160.35395.9e
Abstract
There is growing evidence that essential hypertension is commonly neurogenic and is initiated and sustained by sympathetic nervous system overactivity. Potential mechanisms include increased central sympathetic outflow, altered norepinephrine (NE) neuronal reuptake, diminished arterial baroreflex dampening of sympathetic nerve traffic, and sympathetic neuromodulation by angiotensin II. To address this issue, we used microneurography and radiotracer dilution methodology to measure regional sympathetic activity in 22 hypertensive patients and 11 normotensive control subjects. The NE transport inhibitor desipramine was infused to directly assess the potential role of impaired neuronal NE reuptake. To evaluate possible angiotensin sympathetic neuromodulation, the relation of arterial and coronary sinus plasma concentrations of angiotensin II to sympathetic activity was investigated. Hypertensive patients displayed increased muscle sympathetic nerve activity and elevated total systemic, cardiac, and renal NE spillover. Cardiac neuronal NE reuptake was decreased in hypertensive subjects. In response to desipramine, both the reduction of fractional transcardiac 3[H]NE extraction and the increase in cardiac NE spillover were less pronounced in hypertensive patients. DNA sequencing analysis of the NE transporter gene revealed no mutations that could account for reduced transporter activity. Arterial baroreflex control of sympathetic nerve traffic was not diminished in hypertensive subjects. Angiotensin II plasma concentrations were similar in both groups and were not related to indexes of sympathetic activation. Increased rates of sympathetic nerve firing and reduced neuronal NE reuptake both contribute to sympathetic activation in hypertension, whereas a role for dampened arterial baroreflex restraint on sympathetic nerve traffic and a peripheral neuromodulating influence of angiotensin II appear to be excluded.Keywords
This publication has 14 references indexed in Scilit:
- Sympathetic and cardiac baroreflex function in panic disorderJournal Of Hypertension, 2002
- Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive ratsJournal Of Hypertension, 2001
- Intracoronary blockade of angiotensin‐converting enzyme in humans: Interaction with cardiac sympathetic neurotransmission?Acta Physiologica Scandinavica, 1997
- Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disordersAmerican Journal of Medical Genetics, 1996
- Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertensionJournal Of Hypertension, 1991
- An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasmaJournal Of Hypertension, 1990
- Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.Hypertension, 1989
- Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients.Hypertension, 1981
- Determination of norepinephrine apparent release rate and clearance in humansLife Sciences, 1979
- Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and ageThe Journal of Physiology, 1978